---
title: "Vicarious Surgical Inc. Appoints Stephen From as New CEO Amid Leadership Transition"
description: "Vicarious Surgical Inc. has appointed Stephen From as the new CEO, effective August 7, 2025. Current CEO Adam Sachs will become President and remain a Co-Founder and Board member. The company aims to "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/251061147.md"
published_at: "2025-07-31T20:31:39.000Z"
---

# Vicarious Surgical Inc. Appoints Stephen From as New CEO Amid Leadership Transition

> Vicarious Surgical Inc. has appointed Stephen From as the new CEO, effective August 7, 2025. Current CEO Adam Sachs will become President and remain a Co-Founder and Board member. The company aims to enhance surgical care through innovative robotics under From's leadership, who has over 20 years of experience in healthcare and finance, previously serving as CEO of Aruna Bio and Kiora Pharmaceuticals.

Vicarious Surgical Inc. has appointed Stephen From as its new Chief Executive Officer, effective August 7, 2025. The current CEO, Adam Sachs, will transition to the role of President and continue as a Co-Founder and Board member. The company aims to advance its mission of transforming surgical care through innovative robotics under the new leadership. Stephen From brings over 20 years of experience in the healthcare and financial sectors, previously serving as CEO of Aruna Bio and Kiora Pharmaceuticals, Inc. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vicarious Surgical Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250731473622) on July 31, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)

### Related Stocks

- [RBOT.US - Vicarious Surgical](https://longbridge.com/en/quote/RBOT.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Vicarious Surgical Inc. Held Special Shareholder Meeting | Vicarious Surgical Inc. held a special meeting of stockholders on January 9, 2026, where stockholders approved the exerc | [Link](https://longbridge.com/en/news/272126459.md) |
| Vicarious Surgical Achieves Milestone with Successful In-Vivo Robotic Surgery Lab | Vicarious Surgical Inc. has successfully completed its first in-vivo porcine lab, marking a significant milestone in the | [Link](https://longbridge.com/en/news/272277786.md) |
| Vicarious Surgical Unveils Investor Presentation Showcasing Single-Port Robotic Surgery Platform | Vicarious Surgical Inc. has unveiled an investor presentation highlighting advancements in its single-port robotic surge | [Link](https://longbridge.com/en/news/269755175.md) |
| Officer/Dir Khalifa Files To Sell 653 Of Vicarious Surgical Inc [RBOT] | Khalifa Sammy, an Officer, Director, and Beneficial Owner of Vicarious Surgical Inc, filed a Form 144 with the SEC to se | [Link](https://longbridge.com/en/news/266817129.md) |
| Vicarious Surgical Projects $35 Million Cash Burn for 2026 | Vicarious Surgical Inc. projects a $35 million cash burn for 2026, a $10 million improvement from 2025's guidance. The r | [Link](https://longbridge.com/en/news/269725869.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.